Loewenstein Hospital   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Ra'anana Israel (1959)

Organization Overview

First Clinical Trial
2014
NCT02227056
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Leowenstein Hospital | Loewenstein Hospital | Loewenstein Hospital Rehabiltation Center

Active Ingredients

Drugs in Phase 4 Trials (1)

amantadine (symmetrel) (1 trial)

Drugs in Phase 2 Trials (1)

methylphenidate (ritalin) (1 trial)

Drugs in Other Trials (3)

apixaban (eliquis) (1 trial)

enoxaparin (lovenox) (1 trial)

pregabalin (lyrica) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 4)

Brain Injuries, Traumatic (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5